SEC alleges CellCyte mislead the public

SEC's complaint alleges 'During 2007, CellCyte Genetics Corporation ('CellCyte'), a fledglillg biotechnology company based in Bothell, Washington, repeatedly misled the investing public about its key product, a purported stem cell therapy to treat and repair damaged organs...'
Contributor
About
I am a litigation lawyer, licensed to practice law in the State of California. You can reach me by phone at (310) 286-2000.